KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Jae Lyun Lee
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 10건 중 1-10 번을 표시중입니다.
1
Article
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial
Sumanta K Pal
;
Javier Puente
;
Daniel Y C Heng
;
et al
2022
2
Article
Change of treatment modality and outcomes of adrenocortical carcinoma: a retrospective review of single tertiary center experience over 24 years
Cheong-Sil Rah
;
Jae Won Cho
;
Won Woong Kim
;
et al
2022
3
Article
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor
Inhwan Hwang
;
Inkeun Park
;
Shin-Kyo Yoon
;
et al
2022
4
Article
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Jwa Hoon Kim
;
Gi Hwan Kim
;
Yeon-Mi Ryu
;
et al
2022
5
Article
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure
Shinkyo Yoon
;
Sang Joon Shin
;
Ho Cheol Kim
;
et al
2022
6
Article
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data
Laurence Albiges
;
Daniel Y C Heng
;
Jae Lyun Lee
;
et al
2022
7
Article
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Thomas Powles
;
Piotr Tomczak
;
Se Hoon Park
;
et al
2022
8
Article
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Guru P Sonpavde
;
Cora N Sternberg
;
Yohann Loriot
;
et al
2022
9
Article
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure
Joo-Hwan Park
;
Inkeun Park
;
In-Ho Kim
;
et al
2022
10
Article
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Hyehyun Jeong
;
Kye Jin Park
;
Yongjune Lee
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide